Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
$8.71−0.25 (-2.79%)
Close on Nov 19, 2026Market cap $2.95BP/E –Yield –
Telix Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$42.99M, down 334.0% from the year before.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$42.99M | -334.0% |
| FY2024 | Dec 31, 2024 | $18.37M | +130.6% |
| FY2023 | Dec 31, 2023 | $7.97M | – |
See a number that looks wrong?